Results 241 to 250 of about 407,386 (306)

Epitope-based vaccine of NiV targeting glycoprotein and fusion protein: an integrated immunoinformatics and bioinformatics approach. [PDF]

Virus Res
Aggad WS, Mishra SK, Alqahtani T, Guendouzi A, Tóth Z, Zaki MEA.   +5 more
europepmc   +1 more source

Cross-Reactivity of Antiphospholipid Antibodies with Gut Commensal Proteins in Antiphospholipid Syndrome. [PDF]

TH Open
van Mourik DJM, Balvers M, Jansen VLBI, de Jonge PA, Coppens M, Nieuwdorp M, Middeldorp S, Eikenboom JCJ, Voorberg J, van Mens TE.   +9 more
europepmc   +1 more source

Comparing CD8+ T cell ENV epitopes of two HLA class I alleles associated with different outcomes of HIV-1 infection with broadly neutralizing antibodies epitope targets discovered to date. [PDF]

Front Immunol
Ramdoyal A, Daniuk CA, Omange RW, Kimani J, Luo M.   +4 more
europepmc   +1 more source

Dynamic monitoring of antibody drug conjugates targeting TROP2 or HER2 in breast cancer using circulating tumor cells. [PDF]

Proc Natl Acad Sci U S A
Mishra A, Abelman RO, Cunneely Q, Putaturo V, Deshpande AA, Bell R, Seider EM, Xu KH, Shan M, Kelly J, Huang SB, Rieur O, Knape J, Gopinathan KA, Kikkeri K, Edd JF, Walsh J, Dai CS, Ellisen LW, Ting DT, Nieman L, Toner M, Bardia A, Haber DA, Maheswaran S.   +24 more
europepmc   +1 more source

EXPRESSION OF CONCERN: A Newly Identified 45‐kDa JAK2 Variant with an Altered Kinase Domain Structure Represents a Novel Mode of JAK2 Kinase Inhibitor Resistance

Molecular Oncology, EarlyView.
wiley   +1 more source

Correction to “Differential activity of MEK and ERK inhibitors in BRAF inhibitor resistant melanoma”

Molecular Oncology, EarlyView.
wiley   +1 more source

Design and preparation of multi-epitope mRMA vaccine for Brucella VirB8, OMO25 and other proteins

Wu H, Sai N, Guo J, Yang W, Shen Z, Shen X, Dong Z, Bao L.   +7 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Hypervariable epitope constructs as a means of accounting for epitope variability

Vaccine, 1994
Epitope variability is one of the greatest obstacles to development of synthetic peptide vaccines. Based on a recently described hypervariable epitope (aa 414-434) on the envelope glycoprotein (gp130) to simian immunodeficiency virus (SIVmac142), we have developed a novel approach to account for epitope variability.
A Malley, M B Gardner, Murray B Gardner
exaly   +3 more sources

Mass spectrometric epitope mapping

Mass Spectrometry Reviews, 2018
Reham F El-Kased, Michael Glocker, Kwabena F M Opuni   +2 more
exaly   +2 more sources